Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001103780-11-000032

Chairman/CEO/President bought 17,000 shares at an average $0.29 ($4,960)

From the SEC's structured data for this filing

Trades in this filing

BUNKA CHRISTOPHER · Chairman/CEO/President

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2011-10-24 Purchase : show line 1 in the form +7,000 $0.28 $1,960 1,435,986 D
2011-10-24 Purchase : show line 2 in the form +5,000 $0.32 $1,600 1,440,986 D
2011-10-24 Purchase : show line 3 in the form +5,000 $0.28 $1,400 3,169,659 I
Open-market purchases · 17,000 sh · avg $0.29 · $4,960
Loading xslF345X03/primary_doc.xml…